Akina

Executive Summary

Akina, Inc. is a private research company headquartered near Purdue University in West Lafayette, Indiana, founded in 2001 by Dr. Kinam Park. The company specializes in controlled release, drug delivery, and biomedical applications, operating through two divisions: PolySciTech, which supplies research products and polymers for drug delivery, and Akinalytics, which provides analytical laboratory services. With a focus on enabling advanced drug delivery systems, Akina serves pharmaceutical and biotechnology clients by offering custom synthesis, formulation development, and characterization services. Despite its niche position, the company has not publicly disclosed funding rounds or valuation, and its employee range remains unspecified. As a small but specialized player, Akina is well-positioned to benefit from the growing demand for controlled release technologies and preclinical research support.

Upcoming Catalysts (preview)

• TBDLaunch of new controlled release polymer platform50% success
• Q4 2026Strategic partnership with a mid-sized pharma for formulation services40% success
• TBDExpansion of Akinalytics lab services into new therapeutic areas60% success